02.22
[]. Martin E Dowty, et al. The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans. Drug Metab Dispos. 204 Apr;42(4):759-7.
[2]. Matthias Gehringer, et al. Novel Hinge-Binding Motifs for Janus Kinase Inhibitors: A Comprehensive Structure-Activity Relationship Study on Tofacitinib Bioisosteres. ChemMedChem. 204 Nov;9():25-27.
H02-H5-H9-H5
P2-P24-P270-P27-P280-P02+P52-P04+P40-P0-P2+P4-P405-P50